Argus Investors' Counsel, Inc. Bristol Myers Squibb CO Transaction History

Argus Investors' Counsel, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 06, 2019	SELL	$48.76 - $63.23 $285,441 - $370,148	-5,854 Closed	0 $0
Q3 2018 Oct 16, 2018	BUY	$55.19 - $62.25 $36,039 - $40,649	653 Added 12.56%	5,854 $0
Q2 2018 Jul 19, 2018	BUY	$50.53 - $62.98 $262,806 - $327,558	5,201 New	5,201 $288,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Argus Investors' Counsel, Inc., based on Form 13F filings with the SEC.

Stay updated on Argus Investors' Counsel, Inc. with notifications on news.